Literature DB >> 18475961

Interaction of Cis- and Trans-RuCl (2)(DMSO)(4) With Human Serum Albumin.

L Trynda-Lemiesz1, H Kozlowski, N Katsaros.   

Abstract

The interaction between cis- and trans- RuCl(2)(DMSO)(4) and human serum albumin have been investigated through UV-Vis, circular dichroism, fluorescence spectroscopy and inductively couplet plasma atomic emission spectroscopy (ICP(AES)) method Albumin can specifically bind 1 mole of cis-isomer and 2 moles of the trans-isomer RuCl(2)(DMSO)(4) complex. The interaction of RuCl(2)(DMSO)(4) with HSA causes: a conformational change with the loss of helical stability of protein; the strong quenching of the Trp 214 fluorescence indicating that the conformational change of the hydrophobic binding pocked in subdomain IIA takes place; a local perturbation of the warfarin binding site and induce some conformational changes at neighbour domains, a changing of the binding abilities towards heme.

Entities:  

Year:  2000        PMID: 18475961      PMCID: PMC2365239          DOI: 10.1155/MBD.2000.293

Source DB:  PubMed          Journal:  Met Based Drugs        ISSN: 0793-0291


  3 in total

1.  Interactions of arene-Ru(II)-chloroquine complexes of known antimalarial and antitumor activity with human serum albumin (HSA) and transferrin.

Authors:  Alberto Martínez; Javier Suárez; Tiffany Shand; Richard S Magliozzo; Roberto A Sánchez-Delgado
Journal:  J Inorg Biochem       Date:  2011-01       Impact factor: 4.155

2.  The reduction of (ImH)[trans-RuIIICl4(dmso)(Im)] under physiological conditions: preferential reaction of the reduced complex with human serum albumin.

Authors:  Malgorzata Brindell; Iwona Stawoska; Justyna Supel; Andrzej Skoczowski; Grazyna Stochel; Rudi van Eldik
Journal:  J Biol Inorg Chem       Date:  2008-04-26       Impact factor: 3.358

3.  The binding assessment with human serum albumin of novel six-coordinate Pt(IV) complexes, containing bidentate nitrogen donor/methyl ligands.

Authors:  Reza Yousefi; Asghar Taheri-Kafrani; Sayed Masoud Nabavizadeh; Zahra Pouryasin; Mohammad Bagher Shahsavani; Kazem Khoshaman; Mehdi Rashidi
Journal:  Mol Biol Res Commun       Date:  2015-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.